Jade Biosciences, Inc. (JBIO) Stock Analysis

Jade Biosciences, Inc. (JBIO) is a publicly traded company in the HEALTHCARE sector. It trades at $17.75, carries a market capitalization of $1.04B. This page summarizes the public market data, fundamentals, and frequently asked questions for JBIO, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $17.75
• Market Cap: $1.04B
• EPS: $-2.63
• 52-Week High: $28.00
• 52-Week Low: $6.57

About Jade Biosciences, Inc.

Jade Biosciences, Inc. is a biotechnology company headquartered in Waltham, Massachusetts, specializing in the development of innovative therapies for inflammatory and immunological disorders, particularly autoimmune diseases. The firm is committed to addressing significant unmet medical needs through its proprietary drug development pipeline, which is underpinned by advanced research and scientific rigor. With a focus on transforming patient care in the realm of immunotherapy, Jade Bioscienc...

GNG Research Analysis

GNG Research scores Jade Biosciences, Inc. (JBIO) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for JBIO.

Frequently Asked Questions

Does JBIO pay dividends?

Jade Biosciences, Inc. (JBIO) does not currently pay a regular dividend.

What is JBIO's market cap?

Jade Biosciences, Inc. (JBIO) has a market capitalization of $1.04B with a current stock price of $17.75.